Loading company…
Yavne, Israel biotechnology company developing enzymatic wound care therapies, including the NexoBrid burn treatment, founded in 2000.
MediWound Ltd. develops enzymatic therapeutics for wound care, including NexoBrid, approved in over 40 countries for burn injuries, and EscharEx for chronic wounds. Founded in 2000 and headquartered in Yavne, Israel, the company is led by CEO Ofer Gonen, and Lior Rosenberg is noted as a key founder. It raised USD 25.00 mn in a PIPE round led by Mölnlycke Health Care AB, and reported 2021 revenue of USD 23.76 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in